Chiasmata were counted and paired and unpaired configurations at first meiotic division and chromosome errors at second meiotic division were assessed at different ages in males and females of two strains of laboratory mice. In the females a decrease of chiasma frequency and an increase of univalents at first meiotic metaphase (MI) were confirmed. In the males, diakineses had higher chiasma frequencies (in the range of the female Mis) and fewer univalents than the MIs had. In these male cells there was no decrease of chiasmata or increase of autosomal univalents with age, and there were some interstrain differences. In the older females there was no parallelism between the frequencies of univalents at MI and the chromosome errors that could be identified at second meiotic division; these were fewer than might be expected on the assumption that all the univalents were true univalents. The relevance of this finding to the question of the nature of most of the univalents observed at first meiotic division in aged female mice is discussed.
Diplotene chiasma frequencies from “early” (day 16) fetal oocytes are significantly greater than the average from “late” (day 18) oocytes. A decrease in chiasma frequencies from both ages was found at diakinesis/MI in oocytes of young or old adult females, indicating a loss of chiasmata and/or terminalization. A greater number of type I univalents was found in “late” oocytes than “early” oocytes entering diplotene. No differences were found in chiasma frequencies of male diplotene spermatocytes studied at 23 days, 2 months, or 24 months of age. A greater chiasma frequency was generally found in the female than the male at all ages studied.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.